Anti-Alpha Skeletal Muscle Actin antibody [EPR18430] - Loading Control
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(11 Publications)
Rabbit Recombinant Monoclonal alpha skeletal muscle Actin antibody. Suitable for WB, IHC-P and reacts with Mouse, Rat, Human samples. Cited in 11 publications.
View Alternative Names
ACTA, ACTA1, Alpha-actin-1
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Alpha Skeletal Muscle Actin antibody [EPR18430] - Loading Control (AB184705)
Immunohistochemical analysis of paraffin-embedded Rat skeletal muscle tissue labeling Alpha Skeletal Muscle Actin with ab184705 at 1/100 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Weak cytoplasm staining in rat skeletal muscle is observed.
Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is ab97051 at 1/500 dilution.
Perform heat mediated antigen retrieval with EDTA buffer pH 9 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Alpha Skeletal Muscle Actin antibody [EPR18430] - Loading Control (AB184705)
Immunohistochemical analysis of paraffin-embedded Mouse skeletal muscle tissue labeling Alpha Skeletal Muscle Actin with ab184705 at 1/100 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Weak cytoplasm staining in mouse skeletal muscle is observed.
Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is ab97051 at 1/500 dilution.
Perform heat mediated antigen retrieval with EDTA buffer pH 9 before commencing with IHC staining protocol.
- WB
Supplier Data
Western blot - Anti-Alpha Skeletal Muscle Actin antibody [EPR18430] - Loading Control (AB184705)
All lanes:
Western blot - Anti-Alpha Skeletal Muscle Actin antibody [EPR18430] - Loading Control (ab184705) at 1/1000 dilution
Lane 1:
Human skeletal muscle lysate at 10 µg
Lane 2:
Mouse skeletal muscle lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/10000 dilution
Predicted band size: 42 kDa
Observed band size: 42 kDa
false
Exposure time: 5s
- WB
Supplier Data
Western blot - Anti-Alpha Skeletal Muscle Actin antibody [EPR18430] - Loading Control (AB184705)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Alpha Skeletal Muscle Actin antibody [EPR18430] - Loading Control (ab184705) at 1/1000 dilution
Lane 1:
Mouse brain tissue lysate at 10 µg
Lane 2:
Mouse heart tissue lysate at 10 µg
Lane 3:
Mouse kidney tissue lysate at 10 µg
Lane 4:
Mouse spleen tissue lysate at 10 µg
Lane 5:
Rat brain tissue lysate at 10 µg
Lane 6:
Rat heart tissue lysate at 10 µg
Lane 7:
Rat kidney tissue lysate at 10 µg
Lane 8:
Rat spleen tissue lysate at 10 µg
Lane 9:
Human brain tissue lysate at 10 µg
Lane 10:
Human heart tissue lysate at 10 µg
Lane 11:
Human kidney tissue lysate at 10 µg
Lane 12:
Human spleen tissue lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 42 kDa
Observed band size: 42 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-Alpha Skeletal Muscle Actin antibody [EPR18430] - Loading Control (AB184705)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Alpha Skeletal Muscle Actin antibody [EPR18430] - Loading Control (ab184705) at 1/1000 dilution
All lanes:
Human bladder lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/10000 dilution
Predicted band size: 42 kDa
Observed band size: 42 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-Alpha Skeletal Muscle Actin antibody [EPR18430] - Loading Control (AB184705)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Alpha Skeletal Muscle Actin antibody [EPR18430] - Loading Control (ab184705) at 1/1000 dilution
All lanes:
Rat skeletal muscle lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/10000 dilution
Predicted band size: 42 kDa
Observed band size: 42 kDa
false
Exposure time: 1s
Related conjugates and formulations (1)
-
Anti-Alpha Skeletal Muscle Actin antibody [EPR18430] - BSA and Azide free
Reactivity data
Product details
IHC is recommended for rat and mouse only.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Alpha Skeletal Muscle Actin plays an essential role in the contractile apparatus of muscle cells. It exists as part of the actin filament complex interacting closely with myosin motor proteins. This interaction powers the sliding mechanism that enables muscle contraction and relaxation. Alpha-actin is responsible for mechanical stiffness and tension within muscle tissues enabling muscle fibers to withstand physical stress. The protein's structural role in muscle cells makes it indispensable for proper muscle function and muscle fiber stability.
Pathways
Alpha Skeletal Muscle Actin is deeply involved in the cytoskeletal organization and muscle contraction pathways. It is pivotal in the actin-myosin interaction pathway where it binds to troponin and tropomyosin which regulate muscle contraction cycles. Within these pathways the protein ensures coordinated muscle contractions alongside other proteins like myosin heavy chain and tropomyosin. These interactions coordinate muscle contraction maintaining muscle tone and health.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
BMC nephrology 26:526 PubMed41013408
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Korean journal of pain 38:244-257 PubMed40247654
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell & bioscience 14:102 PubMed39160617
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell communication and signaling : CCS 22:247 PubMed38689280
2024
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10:e2303291 PubMed37553778
2023
Applications
Unspecified application
Species
Unspecified reactive species
Annals of the New York Academy of Sciences 1518:299-314 PubMed36303271
2022
Applications
Unspecified application
Species
Unspecified reactive species
Life (Basel, Switzerland) 12: PubMed36295111
2022
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:1487 PubMed35347124
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 9:630262 PubMed34660566
2021
Applications
Unspecified application
Species
Unspecified reactive species
Translational oncology 14:101171 PubMed34243012
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com